Health and Healthcare
606 Articles
Biogen Idec surprised investors Wednesday with weaker-than-expected guidance for 2014 earnings. Amgen beat estimates late Tuesday. Celgene and Gilead Sciences…
Frank Golhen, via Wikimedia CommonsMost of the firms that we cover on Wall Street have presented their high conviction stock…
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Monday, January 27, 2014.…
Here are some of the top biotech names to buy at Cowen. They presented such an extensive list that we…
In a new research report, the investment strategy team at Credit Suisse is recommending investors look to move out of…
As 2013 begins to wind down, 24/7 Wall St. has started to scan our coverage of Wall Street firms for…
ThinkstockCredit Suisse is out and pounding the table that biotechnology cannot be ignored in 2014. Biotech has been the top-performing…
ThinkstockThe UBS proprietary institutional flow data indicates that hedge funds are increasing exposure to financials and decreasing exposure to health…
courtesy of AOL, IncHeading into the fourth quarter of this year, investors who have been long the stock market are…
ThinkstockThe world of biotechnology investing is a constantly evolving and changing one. While disease for the most part does not…
Jon OggInvestors and traders alike are looking for ideas and recommendations now that the government shutdown is here and with…
Investors and traders are worried about an end to quantitative easing, yet stocks are rallying hard on fundamentals. This puts…
ThinkstockInvestors make big money in biotechnology stocks when they focus on areas that cut across a wide swath of the…
These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Monday, July 1, 2013.…
ThinkstockThe world of biotech investing is always a difficult one. Often a binary event, such as a Food and Drug…
Our top personal finance-related articles today. Your wallet will thank you later.